RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. has recently updated its filings with the SEC, revealing that Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, now hold an 8.9% stake in the fund's 4.75% Series B Cumulative Preferred Shares. This filing, submitted on November 13, 2026, is significant as it reflects the growing interest of major financial institutions in investment funds, particularly in a competitive market.
Background
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. is a publicly traded investment fund listed on the New York Stock Exchange under the ticker symbols OPP, OPP-PA, OPP-PB, and OPP-PC. The fund focuses on strategic investment opportunities, and its recent filings indicate a proactive approach to maintaining investor relations and transparency. The company has undergone name changes in the past, previously known as RiverNorth/DoubleLine Strategic Allocation Fund, Inc., before rebranding in June 2016.
What the Filing Says
The recent Schedule 13G/A filing states that Morgan Stanley and Morgan Stanley Smith Barney LLC have beneficially owned a total of 212,407 shares, which constitutes 8.9% of the preferred shares. The filing indicates that both entities share voting power but do not possess sole voting or dispositive power over the shares.
Impact
This updated filing may affect various stakeholders, including existing shareholders of RiverNorth/DoubleLine and potential investors looking to gauge the fund's market confidence. The involvement of Morgan Stanley, a major player in the financial services industry, could enhance the fund's credibility and attract further investments.
What's Next
The filing does not say what happens next.
Read Next
Oaktree Capital Management Updates Stake in Quantum Corporation
Morgan Stanley Reduces Stake in MIND CTI LTD to Below 5%
Morgan Stanley Updates Ownership in Kayne Anderson Fund
Great Lakes Advisors Increases Stake in American Century ETF Trust
ST-1014 Fund I acquires 9.6% stake in Standard Nuclear
TD Securities Discloses 4.6% Stake in OneMedNet Corp



